While overall no significant difference in plasma PTX3 levels was observed between patients with TC and benign thyroid disease, increased PTX3 expression was found in patients with ATC, suggesting its potential association with the aggressive clinical phenotype of this cancer subtype. Here, PTX3 is linked to cancer.